Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Biophys J ; 109(2): 390-7, 2015 Jul 21.
Article in English | MEDLINE | ID: mdl-26200875

ABSTRACT

Viral particles are endowed with physicochemical properties whose modulation confers certain metastability to their structures to fulfill each task of the viral cycle. Here, we investigate the effects of swelling and ion depletion on the mechanical stability of individual tomato bushy stunt virus nanoparticles (TBSV-NPs). Our experiments show that calcium ions modulate the mechanics of the capsid: the sequestration of calcium ions from the intracapsid binding sites reduces rigidity and resilience in ∼24% and 40%, respectively. Interestingly, mechanical deformations performed on native TBSV-NPs induce an analogous result. In addition, TBSV-NPs do not show capsomeric vacancies after surpassing the elastic limit. We hypothesize that even though there are breakages among neighboring capsomers, RNA-capsid protein interaction prevents the release of capsid subunits. This work shows the mechanical role of calcium ions in viral shell stability and identifies TBSV-NPs as malleable platforms based on protein cages for cargo transportation at the nanoscale.


Subject(s)
Calcium/chemistry , Nanoparticles/chemistry , Tombusvirus/chemistry , Elasticity , Ions/chemistry , Microscopy, Atomic Force , Microscopy, Electron, Transmission , Nicotiana , Tombusvirus/isolation & purification
2.
Biochim Biophys Acta ; 1840(6): 1958-64, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24576672

ABSTRACT

BACKGROUND: TP53 tumor suppressor gene is mutated in more than 50% of human tumors. Mutated p53 proteins could sequestrate and inactivate p73 reducing the apoptotic and anti-proliferative effects of the transcription factor, and yielding cancer cells more aggressive and chemoresistant. The possibility of using drugs to prevent the mutant p53/p73 complex formation preserving the p73 function, calls for a deeper insight into the molecular and biochemical mechanisms of mutant p53/p73 protein interaction. METHODS: The kinetics of the mutant p53R175H/p73 complex was investigated with innovative and complementary techniques, operating in real time, in near physiological conditions and without any labeling. Specifically, Atomic Force Spectroscopy and Surface Plasmon Resonance working at single-molecule level and in bulk condition, respectively, were used. RESULTS: The two techniques revealed that a stable complex is formed between mutant p53R175H and p73 proteins; the complex being characterized by a high interaction force and a dissociation equilibrium constant in the order of 10(-7)M, as expected for specific interactions. No binding was instead observed between p73 and wild type p53. CONCLUSIONS: Mutant p53R175H protein, unlike wild type p53, can form a stable complex with p73. The mutant p53R175H/p73 protein complex could be a target for innovative pharmaceutical drugs that, by dissociating it or preventing biomolecule interaction thus preserving the p73 function, could enhance the response of cancerous cells carrying mutant p53R175H protein to common chemotherapeutic agents. GENERAL SIGNIFICANCE: The kinetic information obtained in vitro may help to design specific pharmaceutical drugs directed against cancerous cells carrying mutant p53 proteins.


Subject(s)
DNA-Binding Proteins/chemistry , Microscopy, Atomic Force/methods , Nuclear Proteins/chemistry , Surface Plasmon Resonance/methods , Tumor Suppressor Protein p53/chemistry , Tumor Suppressor Proteins/chemistry , DNA-Binding Proteins/ultrastructure , Humans , Mutation , Nuclear Proteins/ultrastructure , Tumor Protein p73 , Tumor Suppressor Protein p53/ultrastructure , Tumor Suppressor Proteins/ultrastructure
3.
Biophys Chem ; 211: 19-27, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26803406

ABSTRACT

ß2-Microglobulin (B2M) is a human protein involved in the regulation of immune response and represents a useful biomarker for several diseases. Recently, anti-B2M monoclonal antibodies have been introduced as innovative therapeutic agents. A deeper understanding of the molecular interaction between the two partners could be of utmost relevance for both designing array-based analytical devices and improving current immunotherapies. A visualization at the nanoscale performed by Atomic Force Microscopy revealed that binding of B2M to the antibody occurred according to two preferred interaction geometries. Additionally, Atomic Force Spectroscopy and Surface Plasmon Resonance provided us with detailed information on the binding kinetics and the energy landscape of the complex, both at the single molecule level and in bulk conditions. Combination of these complementary techniques contributed to highlight subtle differences in the kinetics behaviour characterizing the complexes. Collectively, the results may deserve significant interest for designing, development and optimization of novel generations of nanobiosensor platforms.


Subject(s)
Antibodies, Monoclonal/chemistry , Antibodies, Monoclonal/immunology , Antigen-Antibody Reactions , Microscopy, Atomic Force , Surface Plasmon Resonance , beta 2-Microglobulin/chemistry , beta 2-Microglobulin/immunology , Binding Sites, Antibody/immunology , Humans , Kinetics
4.
Int J Nanomedicine ; 9: 1799-813, 2014.
Article in English | MEDLINE | ID: mdl-24748790

ABSTRACT

p28 is an anionic, amphipathic, cell-penetrating peptide derived from the cupredoxin azurin that binds to the DNA-binding domain (DBD) of the tumor suppressor protein, p53, and induces a post-translational increase in the level of wild type and mutated p53 in a wide variety of human cancer cells. As p63 and p73, additional members of the p53 superfamily of proteins, also appear to be involved in the cellular response to cancer therapy and are reportedly required for p53-induced apoptosis, we asked whether p28 also binds to p63 and p73. Atomic force spectroscopy demonstrates that p28 forms a stable, high-affinity complex with full-length p63, the DBD of p63, and full-length p73. Exposure to p28 decreased the level of TAp63α and ΔNp63α, the truncated form of p63, in p53 wild type and mutated human breast cancer cells, respectively. p28 increased the level of TAp73α, but not ΔNp73α, in the same breast cancer cell lines. In contrast, p28 increased the level of the TA and ΔN isoforms of p63 in p53 wild type, but not in p53 mutated melanoma cells, while decreasing TA p73α in p53 wild type and mutated human melanoma cells. All changes were mirrored by an associated change in the expression of the HECT E3 ligases Itch/AIP4, AIP5, and the RING E3 ligase Pirh2, but not in the receptor for activated C kinase or the RING E3 ligases Mdm2 and Cop1. Collectively, the data suggest that molecules such as p28 bind with high affinity to the DBD of p63 and p73 and alter their expression independent of the Mdm2 and Cop1 pathways.


Subject(s)
Azurin/chemistry , Azurin/immunology , Neoplasms, Experimental/immunology , Peptide Fragments/chemistry , Peptide Fragments/immunology , Tumor Suppressor Protein p53/chemistry , Tumor Suppressor Protein p53/metabolism , Antineoplastic Agents/immunology , Azurin/ultrastructure , Binding Sites , Cell Line, Tumor , Computer Simulation , Humans , Models, Chemical , Models, Immunological , Models, Molecular , Neoplasms, Experimental/chemistry , Peptide Fragments/ultrastructure , Protein Binding , Protein Interaction Mapping , Tumor Suppressor Protein p53/ultrastructure
5.
Int J Nanomedicine ; 6: 3011-9, 2011.
Article in English | MEDLINE | ID: mdl-22162658

ABSTRACT

p28 is a 28-amino acid peptide fragment of the cupredoxin azurin derived from Pseudomonas aeruginosa that preferentially penetrates cancerous cells and arrests their proliferation in vitro and in vivo. Its antitumor activity reportedly arises from post-translational stabilization of the tumor suppressor p53 normally downregulated by the binding of several ubiquitin ligases. This would require p28 to specifically bind to p53 to inhibit specific ligases from initiating proteosome-mediated degradation. In this study, atomic force spectroscopy, a nanotechnological approach, was used to investigate the interaction of p28 with full-length p53 and its isolated domains at the single molecule level. Analysis of the unbinding forces and the dissociation rate constant suggest that p28 forms a stable complex with the DNA-binding domain of p53, inhibiting the binding of ubiquitin ligases other than Mdm2 to reduce proteasomal degradation of p53.


Subject(s)
Antineoplastic Agents/metabolism , Azurin/metabolism , Peptide Fragments/metabolism , Tumor Suppressor Protein p53/metabolism , Antineoplastic Agents/chemistry , Azurin/chemistry , Humans , Immobilized Proteins/chemistry , Immobilized Proteins/metabolism , Microscopy, Atomic Force , Peptide Fragments/chemistry , Protein Binding , Protein Interaction Domains and Motifs , Pseudomonas aeruginosa/chemistry , Spectrum Analysis , Tumor Suppressor Protein p53/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL